Ghryvelin (Macimorelin)

Ghryvelin (Macimorelin) is an oral medication used to stimulate growth hormone secretion. It is commonly prescribed for diagnostic purposes to assess growth hormone deficiency. This medication is manufactured by Atnahs Pharma Netherlands B.V.

Ghryvelin is primarily used to stimulate the release of growth hormone in the body. This can help in diagnosing growth hormone deficiency by measuring the body's response to the medication. It is often used in clinical settings to evaluate the pituitary gland's function and growth hormone production.

When taken as directed, Ghryvelin may cause an increase in growth hormone levels. Some individuals might experience temporary side effects such as dizziness, headache, or nausea. These effects are generally mild and short-lived. Always consult a healthcare provider for personalized advice.

Ghryvelin should be used with caution in individuals with a history of heart conditions or seizures. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Keep the medication out of reach of children and store it as directed.

Ghryvelin may interact with other medications, including those that affect growth hormone levels or metabolism. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Avoid alcohol while using this medication unless advised otherwise.